SCHEMBL13076264

SCHEMBL13076264

O=C(Nc1ccc(F)cc1)c1ccc(-c2c[nH]c(-c3c(F)cccc3Cl)n2)cn1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GCGR P47871 3/20 0.42
NPC1 O15118 1/20 0.42
ALDH1A1 P00352 1/20 0.42
GAA P10253 1/20 0.42
RAB9A P51151 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
P4HTM Q9NXG6 3/20 0.41
PTPN1 P18031 1/20 0.41
PTPN6 P29350 1/20 0.41
PTPN11 Q06124 1/20 0.41
MAPT P10636 1/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
MAPK7 Q13164 2/20 0.41
RXFP1 Q9HBX9 1/20 0.41
NR2E3 Q9Y5X4 1/20 0.40
MAOB P27338 1/20 0.39
SMO Q99835 1/20 0.39
KCNQ3 O43525 1/20 0.39
KCNQ2 O43526 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13075541 0.93 KDM4E (0.43) GCGRNPC1ALDH1A1RAB9AP4HTM
SCHEMBL13075525 0.92 MAPK7 (0.43) GCGRNPC1RAB9ASMN1; SMN2P4HTM
SCHEMBL13075530 0.91 SMN1; SMN2 (0.43) GCGRNPC1RAB9ASMN1; SMN2MEN1
SCHEMBL13075516 0.87 NPC1 (0.46) GCGRNPC1RAB9ASMN1; SMN2P4HTM
SCHEMBL13075531 0.86 LMNA (0.50) GCGRALDH1A1GAASMN1; SMN2MAPT
SCHEMBL13075532 0.86 GCGR (0.40) GCGRMAPK7NR2E3MAOBATR
SCHEMBL3795491 0.85 PTGES (0.43) GCGRP4HTM
SCHEMBL3796557 0.84 PTGES (0.53) GCGRNPC1ALDH1A1GAARAB9A
SCHEMBL29662800 0.82 PTGES (0.43)
SCHEMBL3799056 0.81 PTGES (0.40) GCGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010127152-A2 COMPOUNDS AND COMPOSITIONS AS MICROSOMAL PROSTAGLANDIN E SYNTHASE-1 INHIBITORS IRM LLC (BM) 2010-11-04 WO disclosed